Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the several main areas, including: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; and Surgical Structural Heart, which is engaged in resilient surgical therapies.
When researching a stock like Edwards Lifesciences, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from EW Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for EW stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the EW 200 day moving average ("EW 200 DMA"), while one of the most popular "shorter look-backs" is the EW 50 day moving average ("EW 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Edwards Lifesciences. |
Free EW Email Alerts:
Video: Technical Analysis